Stay updated on IMpower131 Atezolizumab Combo in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the IMpower131 Atezolizumab Combo in Advanced NSCLC Clinical Trial page.

Latest updates to the IMpower131 Atezolizumab Combo in Advanced NSCLC Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.4.3 was added to the history and Revision: v3.4.2 was removed.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added to the history; the funding-lapse notice and Revision: v3.4.1 were removed.SummaryDifference0.4%

- Check41 days agoChange DetectedAdded a government funding notice banner and updated the page revision to v3.4.1, removing the previous v3.4.0 reference.SummaryDifference0.4%

- Check48 days agoChange DetectedThe history page adds a glossary toggle and color-coded indicators for additions (green) and deletions (red), and updates the revision label from v3.3.4 to v3.4.0.SummaryDifference0.5%

- Check62 days agoChange DetectedThe page revision label changed from v3.3.3 to v3.3.4 on the Record History page, with no changes to trial data.SummaryDifference0.1%

- Check84 days agoChange DetectedFooter area updates: added 'Revision: v3.3.3' and removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'. These changes affect navigation text and do not alter the study record content or data.SummaryDifference0.1%

Stay in the know with updates to IMpower131 Atezolizumab Combo in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMpower131 Atezolizumab Combo in Advanced NSCLC Clinical Trial page.